Safety, pharmacokinetics and antiviral effect of BILB1941, a novel HCVRNA polymerase inhibitor, after 5 days oral treatment in patients with chronic hepatitis C

被引：10

作者：

Erhardt, A.

Wedemeyer, H.

Benhamou, Y.

Moellekens, C.

Foms, X.

Pol, S.

Calleja, J. L.

Ross, S.

Spangenberg, H. C.

Garcia-Samaniego, J.

Fuchs, M.

Enriquezo, J.

Wiegand, J.

Stern, J.

Wu, K.

Nehmiz, G.

Stefilgen, J.

机构：

[1] Univ Klin Dusseldorf, F-75634 Dusseldorf, Germany

[2] Hannover Med Sch, Hannover, Germany

[3] Grp Hosp Pitie Salpetriere, Paris, France

[4] Univ Klin Bochum, F-75674 Bochum, Germany

[5] Hosp Clin Barcelona, Barcelona, Spain

[6] Hop Cochin, Paris, France

[7] Clin Puerta de Hierro, Madrid, Spain

[8] Univ Klin Kiel, Kiel, Germany

[9] Univ Klin Freiburg, Freiburg, Germany

来源：

关键词：

D O I：

10.1016/S0168-8278(07)62184-9

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

586

引用

页码：S222 / S222

页数：1